Journal article
Polyunsaturated fatty acids (PUFA) for attention deficit hyperactivity disorder (ADHD) in children and adolescents
Cochrane Database of Systematic Reviews, Vol.2012(7), CD007986
2012
PMID: 22786509
Metrics
26 Record Views
UN Sustainable Development Goals (SDGs)
This output has contributed to the advancement of the following goals:
Source: InCites
Abstract
Attention deficit hyperactivity disorder (ADHD) is a major problem in children and adolescents and can result in long‐term social, academic and mental health problems. Stimulant medications, such as methylphenidate and amphetamine, are the most frequently used treatments for ADHD but are not always effective and can be associated with side effects. There is evidence that ADHD could be related to deficiencies of polyunsaturated fatty acids (PUFA) and, in particular, omega‐3 PUFA; therefore, PUFA supplementation may improve ADHD symptoms and associated problems. The aim of this review was to evaluate whether PUFA supplements are an effective treatment for children and adolescents with ADHD. Although there were some limited data that did indicate there may be some improvement, overall there was little evidence that PUFA supplementation is beneficial. Further high‐quality research needs to be done.
Details
- Title
- Polyunsaturated fatty acids (PUFA) for attention deficit hyperactivity disorder (ADHD) in children and adolescents
- Creators
- Donna Gillies - Western Sydney and Nepean Blue Mountains Local Health Districts ‐ Mental HealthJohn KH Sinn - Royal North Shore Hospital, The University of SydneySagar S Lad - Jehangir Apollo HospitalMatthew John Leach - University of South AustraliaMelissa J Ross - Westmead Hospital
- Publication Details
- Cochrane Database of Systematic Reviews, Vol.2012(7), CD007986
- Publisher
- John Wiley & Sons, Ltd
- Identifiers
- 991012911992602368
- Academic Unit
- National Centre for Naturopathic Medicine; Faculty of Health
- Language
- English
- Resource Type
- Journal article